https://www.selleckchem.com/products/tlr2-in-c29.html tion) for the prevention of hypertension in a population with a long-term adherence to predominantly plant-based diets.A novel BTEX degrading bacterial strain, designated ML15P13T, was isolated from Arctic soil at the Svalbard Islands, Norway, using an enrichment culture technique. This isolate is Gram-negative, aerobic, motile with multiple flagella at one polar end, and rod-shaped. Growth was observed at 4-35 °C, pH 6.0-8.0, and 0-0.5% (w/v) NaCl. According to 16S rRNA gene analysis, strain ML15P13T was grouped with members of the genus Massilia and closely related to Massilia atriviolacea SODT (98.4%), Massilia violaceinigra B2T (98.3%), Massilia eurypsychrophila B528-3T (97.7%), Massilia glaciei B448-2T (97.7%), and Massilia psychrophila B115-1T (96.6%). Average nucleotide identity, digital DNA-DNA hybridization, and average amino acid identity between genome sequences of strain ML15P13T and the closely related species ranged from 75.8 to 84.3%, from 19.6 ± 1.0 to 21.6 ± 0.3%, and from 68.8 to 71.0%, respectively. The major fatty acids were C160, summed feature 3 (C161 ω6c and/or C161 ω7c), and summed feature 8 (C181 ω7c and/or C181 ω6c). Q-8 was the major ubiquinone. The polar lipid profile showed the presence of phosphatidylethanolamine, phosphatidylglycerol, diphosphatidylglycerol, one unidentified phospholipid, and five unidentified polar lipids. The G + C content of the genomic DNA was 64.2 mol%. Based on the results for genotypic and phenotypic study, we conclude that strain ML15P13T represents a novel species of the genus Massilia, for which the name Massilia aromaticivorans sp. nov. is proposed. The type strain is ML15P13T (= KACC 21773T = JCM 34089T). To assess the efficacy of phloroglucinol for acceleration of labour. Randomized controlled trials (RCTs) comparing phloroglucinol with placebo were searched in PubMed, Embase and the Cochrane Library. Literatures were collected up to April 2020. Primary